IL95824A0 - Peptides associated with cd4 binding region of gp120 and their use - Google Patents

Peptides associated with cd4 binding region of gp120 and their use

Info

Publication number
IL95824A0
IL95824A0 IL95824A IL9582490A IL95824A0 IL 95824 A0 IL95824 A0 IL 95824A0 IL 95824 A IL95824 A IL 95824A IL 9582490 A IL9582490 A IL 9582490A IL 95824 A0 IL95824 A0 IL 95824A0
Authority
IL
Israel
Prior art keywords
binding region
peptides associated
peptides
binding
region
Prior art date
Application number
IL95824A
Original Assignee
Idec Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idec Pharma Corp filed Critical Idec Pharma Corp
Publication of IL95824A0 publication Critical patent/IL95824A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • AIDS & HIV (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL95824A 1989-09-22 1990-09-27 Peptides associated with cd4 binding region of gp120 and their use IL95824A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41106389A 1989-09-22 1989-09-22
US58494890A 1990-09-18 1990-09-18

Publications (1)

Publication Number Publication Date
IL95824A0 true IL95824A0 (en) 1991-06-30

Family

ID=27021259

Family Applications (1)

Application Number Title Priority Date Filing Date
IL95824A IL95824A0 (en) 1989-09-22 1990-09-27 Peptides associated with cd4 binding region of gp120 and their use

Country Status (6)

Country Link
EP (1) EP0493508A1 (en)
AU (1) AU6523590A (en)
CA (1) CA2066607A1 (en)
IE (1) IE903433A1 (en)
IL (1) IL95824A0 (en)
WO (1) WO1991004273A2 (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637677A (en) 1987-07-16 1997-06-10 The Trustees Of The University Of Pennsylvania Biologically active compounds and methods of constructing and using the same
ATE148918T1 (en) * 1989-04-25 1997-02-15 Tanox Biosystems Inc ANTIBODIES SPECIFIC TO THE CO4-BINDING DOMAIN OF HIV
JP3494300B2 (en) * 1990-04-03 2004-02-09 ジェネンテック・インコーポレーテッド Methods and compositions for vaccination against HIV
US7041293B1 (en) 1990-04-03 2006-05-09 Genentech, Inc. HIV env antibodies
AP237A (en) * 1990-05-29 1993-04-29 Cedars Sinai Medical Center Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type 1 (HIV-1) gp120 and methods of use.
CA2047042A1 (en) * 1990-07-19 1992-01-20 John Hannah Cyclic hiv principal neutralizing determinant peptides
CA2047033A1 (en) * 1990-07-19 1992-01-20 Elizabeth E. Sugg Cyclic hiv principal neutralizing determinant peptides
CA2047078A1 (en) * 1990-07-19 1992-01-20 Steven S. Bondy Cyclic hiv principal neutralizing determinant peptides
ATE229974T1 (en) * 1990-09-14 2003-01-15 Univ Pennsylvania DESIGN OF BIOACTIVE PEPTIDES BASED ON IMMUNOGLOBULIN STRUCTURES
JPH05262662A (en) * 1991-07-15 1993-10-12 Calpis Food Ind Co Ltd:The Hiv superinfection preventive, antigen for preparing anti-idiotype antibody and production of anti-idiotype antibody
DE69328726D1 (en) * 1992-02-10 2000-06-29 Univ Durham USE OF SYNTHETIC PEPTIDES FOR INDUCING TOLERANCE AGAINST T AND B CELL EPITOPES OF AUTOANTIGENS
US5556744A (en) * 1992-05-29 1996-09-17 The Trustees Of The University Of Pennsylvania Methods and compositions for diagnosing and treating certain HIV infected patients
AU700371B2 (en) 1993-06-07 1999-01-07 Genentech Inc. Hiv envelope polypeptides
DE69508382D1 (en) * 1994-01-19 1999-04-22 Us Health PEPTOMERS WITH INCREASED IMMUNOGENICITY
DE4405810A1 (en) 1994-02-23 1995-08-24 Behringwerke Ag Peptides derived from a retrovirus from the HIV group and their use
US5691447A (en) * 1995-03-24 1997-11-25 Tanox Biosystems, Inc. GC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodies
US6585979B1 (en) 1996-07-08 2003-07-01 Genentech, Inc. HIV envelope polypeptides and immunogenic composition
ZA975889B (en) * 1996-07-08 1998-02-23 Genentech Inc HIV envelope polypeptides and vaccine.
JP2003523721A (en) 1998-12-31 2003-08-12 カイロン コーポレイション Polynucleotides encoding antigenic HIVC-type polypeptides, polypeptides, and uses thereof
ES2299276T3 (en) 1998-12-31 2008-05-16 Novartis Vaccines And Diagnostics, Inc. MODIFIED HIV ENV POLIPEPTIDES.
CA2360347C (en) 1998-12-31 2013-05-07 Chiron Corporation Improved expression of hiv polypeptides and production of virus-like particles
WO2001083535A2 (en) * 2000-05-02 2001-11-08 Simon Fraser University Polypeptides for use as a vaccine and/or treatment for hiv infection
US7211659B2 (en) 2001-07-05 2007-05-01 Chiron Corporation Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof
US20030170614A1 (en) 2001-08-31 2003-09-11 Megede Jan Zur Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
US20100009340A1 (en) * 2006-04-05 2010-01-14 The Regents Of The University Of California Compositions and methods for the analysis and treatment of aids wasting syndrome and immune cell dysfunction
JP5867795B2 (en) * 2007-02-01 2016-02-24 テーツェーエフ ゲゼルシャフト ミット ベシュレンクテル ハフツング Specific activation of regulatory T cells and their use for the treatment of asthma, allergic diseases, autoimmune diseases, graft rejection and induction of immune tolerance
EP2452947A1 (en) * 2010-11-16 2012-05-16 Münch, Jan Viral infection enhancing peptide
EP2492279A1 (en) 2011-02-25 2012-08-29 Laboratorios Del. Dr. Esteve, S.A. Rapid immunogen selection method using lentiviral display
EP2698377A1 (en) 2012-08-17 2014-02-19 Laboratorios Del. Dr. Esteve, S.A. Enhanced rapid immunogen selection method for HIV gp120 variants

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3787002T2 (en) * 1986-12-30 1993-11-25 Us Health Synthetic peptides that generate cellular immunity to the AIDS virus and its proteins.
ES2102347T3 (en) * 1987-02-20 1997-08-01 Genentech Inc METHODS AND COMPOSITIONS FOR THE USE OF ENV POLYPEPTIDES AND ANTI-ENV ANTIBODIES OF HIV.
IL87391A0 (en) * 1987-08-27 1989-01-31 Repligen Corp Hiv proteins and peptides,dna coding therefor,vectors comprising such dna,the use of the proteins and peptides in diagnosis of aids and vaccine compositions containing them
CA1341285C (en) * 1988-02-12 2001-08-14 Chang Yi Wang Synthetic peptides for the detection of antibodies to hiv gp120 envelope protein for diagnosis of aids and pre-aids conditions and as vaccines
EP0330359A3 (en) * 1988-02-25 1991-06-05 Bio-Rad Laboratories, Inc. Composition useful in the diagnosis and treating of hiv-1 infection

Also Published As

Publication number Publication date
WO1991004273A2 (en) 1991-04-04
EP0493508A1 (en) 1992-07-08
IE903433A1 (en) 1991-04-10
CA2066607A1 (en) 1991-03-23
AU6523590A (en) 1991-04-18
WO1991004273A3 (en) 1991-05-02

Similar Documents

Publication Publication Date Title
IL95824A0 (en) Peptides associated with cd4 binding region of gp120 and their use
NZ220653A (en) Hiv env region peptides and d-retro versions thereof
IL91843A0 (en) Hiv proteins and peptides useful in the diagnosis,prophylaxis aids or therapy of aids
EP0343526A3 (en) Novel polymer and its preparation and use
NZ224046A (en) Hiv antigenic peptide fragments and their use
IL87902A0 (en) Soluble human cd4 fragments and applications thereof
EP0351314A3 (en) Medical material and medical implement
IL90690A0 (en) Tissue equivalents and their preparation
EP0491844A4 (en) Peptides including ctl epitopes of hiv proteins and use thereof
JPS6454032A (en) Polydisilacyclobutasilazane and its preparation and use
AU6428890A (en) Therapeutic peptides and proteins
GB2203740B (en) Novel peptides, their preparation and use
AU633294B2 (en) Motilin-like polypeptide and use thereof
PH25149A (en) Cyclic peptides and their preparation
ZA886273B (en) Novel hiv proteins and peptides useful in the diagnosis,prophylaxis or therapy of aids
EP0435199A3 (en) Acrylic gel material and acrylic gel preparation
GB8919726D0 (en) Ws7338 substances and preparation thereof
IL83347A0 (en) Recombinant htlv-iii proteins and their use
IL87730A0 (en) Peptides and antibodies
NZ227594A (en) Human interleukin-1alpha and preparations thereof
IL92281A0 (en) Polyimidesiloxanes,their preparation and use
EP0438628A3 (en) Polymerisable mixture and its preparation
AU2623088A (en) New anti-receptor peptides and therapeutic agents
GB8920304D0 (en) Fr901375 substance and preparation thereof
EP0438629A3 (en) Polymerisable mixture and its preparation